Search

Your search keyword '"Willem Weimar"' showing total 611 results

Search Constraints

Start Over You searched for: Author "Willem Weimar" Remove constraint Author: "Willem Weimar"
611 results on '"Willem Weimar"'

Search Results

101. FoxP3 cells and the pathophysiologic effects of brain death and warm ischemia in donor kidneys

102. Randomized Phase 2b Trial of Tofacitinib (CP-690,550) in De Novo Kidney Transplant Patients: Efficacy, Renal Function and Safety at 1 Year

103. Incentives for Organ Donation: Proposed Standards for an Internationally Acceptable System

104. ATP-binding cassette transporters as pharmacogenetic biomarkers for kidney transplantation

105. Pharmacodynamic Analysis of Tofacitinib and Basiliximab in Kidney Allograft Recipients

106. Terminally Differentiated CD8(+) Temra Cells Are Associated With the Risk for Acute Kidney Allograft Rejection

107. A Criminological Perspective: Why Prohibition of Organ Trade Is Not Effective and How the Declaration of Istanbul Can Move Forward

108. Phosphospecific flow cytometry for pharmacodynamic drug monitoring: Analysis of the JAK-STAT signaling pathway

109. Can we turn down autonomous wishes to donate anonymously?

110. Polymorphisms in CYP3A5, CYP3A4, and ABCB1 are Not Associated With Cyclosporine Pharmacokinetics Nor With Cyclosporine Clinical End Points After Renal Transplantation

111. Living kidney donors

112. A case of primary aldosteronism revealed after renal transplantation

113. Current immunosuppressive treatment after kidney transplantation

114. Discontinuation of calcineurin inhibitors treatment allows the development of FOXP3+ regulatory T-cells in patients after kidney transplantation

115. Posttransplantation Encapsulating Peritoneal Sclerosis Contributes Significantly to Mortality after Kidney Transplantation

116. Patient survival after the diagnosis of cancer in renal transplant recipients

117. The optimal chain length for kidney paired exchanges: an analysis of the Dutch program

118. Efficacy of Rabbit Anti-Thymocyte Globulin Therapy for Severe Acute Rejection in Kidney Transplant Patients using Calcineurin Inhibitor and Mycophenolate Mofetil based Immunosuppressive Therapy

119. Impact after Live Donor Nephrectomy

120. Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study

121. Optimizing left-sided live kidney donation: hand-assisted retroperitoneoscopic as alternative to standard laparoscopic donor nephrectomy

122. High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation

123. Circulating pro-inflammatory CD4posCD28null T cells are independently associated with cardiovascular disease in ESRD patients

124. Cell contact interaction between adipose-derived stromal cells and allo-activated T lymphocytes

125. Interpatient variability in IMPDH activity in MMF-treated renal transplant patients is correlated with IMPDH type II 3757T>C polymorphism

126. A Multiplex Bead Array Analysis to Monitor Donor-Specific Cytokine Responses After Withdrawal of Immunosuppression in HLA-Identical living Related Kidney Transplant Patients

127. Inadequate Immune Regulatory Function of CD4+CD25bright+FoxP3+ T Cells in Heart Transplant Patients who Experience Acute Cellular Rejection

128. Donor-Derived Mesenchymal Stem Cells Suppress Alloreactivity of Kidney Transplant Patients

129. Successful Tapering of Immunosuppression to Low-Dose Monotherapy Steroids After Living-Related Human Leukocyte Antigen-Identical Renal Transplantation

130. Strategies to advance living kidney donation: a single center's experience

131. The effect of rabbit anti-thymocyte globulin induction therapy on regulatory T cells in kidney transplant patients

132. Clinical rejection and persistent immune regulation in kidney transplant patients

133. T-Cell Reactivity During Tapering of Immunosuppression to Low-Dose Monotherapy Prednisolone in HLA-Identical Living-Related Renal Transplant Recipients

134. Deficient TNF-alpha and IFN-gamma Production Correlates With Nondetectable Donor-Specific Cytotoxicity After Clinical Kidney Transplantation

135. Monotherapy rapamycin allows an increase of CD4(+) CD25(bright+) FoxP3(+) T cells in renal recipients

136. CMV Seropositivity Determines Epoetin Dose and Hemoglobin Levels in Patients with CKD

137. Regulatory T cells in alloreactivity after clinical heart transplantation

138. Pre-kidney-transplant blood transfusions do not improve transplantation outcome: a Dutch national study

139. Non-HLA T-cell reactivity during the first year after HLA-identical living-related kidney transplantation

140. The Effect of the JAK Inhibitor CR-690,550 on Peripheral Immune Parameters in Stable Kidney Allograft Patients

141. Donor-Derived Mesenchymal Stem Cells Remain Present and Functional in the Transplanted Human Heart

142. Inosine Monophosphate Dehydrogenase Messenger RNA Expression Is Correlated to Clinical Outcomes in Mycophenolate Mofetil-Treated Kidney Transplant Patients, Whereas Inosine Monophosphate Dehydrogenase Activity Is Not

143. Potential of mesenchymal stem cells as immune therapy in solid-organ transplantation

144. Blood dendritic cell levels and phenotypic characteristics in relation to etiology of end-stage heart failure: Implications for dilated cardiomyopathy

145. Avoiding the issue: Patients' (non)communication with potential living kidney donors

146. End-stage renal failure and regulatory activities of CD4(+)CD25(bright+)FoxP3(+) T-cells

147. Associations between pre-kidney-transplant risk factors and post-transplant cardiovascular events and death

148. Functional analysis of CD4+ CD25bright T cells in kidney transplant patients: improving suppression of donor-directed responses after transplantation

149. Donor-reactive cytokine profiles after HLA-identical living-related kidney transplantation

150. The control of anti-donor immune responses by regulatory T cells in organ transplant patients

Catalog

Books, media, physical & digital resources